Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- Sandostatin LAR Depot (octreotide)
- spironolactone
Interactions between your drugs
No drug ⬌ drug interactions were found between the drugs in your list. However, this does not necessarily mean no drug interactions exist. Always consult your healthcare provider.
Drug and food interactions
octreotide food
Applies to: Sandostatin LAR Depot (octreotide)
Octreotide may affect the absorption of dietary nutrients and medications that you take by mouth, including some vitamin and nutritional supplements. Contact your doctor if your condition changes. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
spironolactone food
Applies to: spironolactone
Spironolactone and ethanol (alcohol) may have additive effects in lowering your blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate. These side effects are most likely to be seen at the beginning of treatment, following a dose increase, or when treatment is restarted after an interruption. Let your doctor know if you develop these symptoms and they do not go away after a few days or they become troublesome. Avoid driving or operating hazardous machinery until you know how the medications affect you, and use caution when getting up from a sitting or lying position. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Sandostatin
Sandostatin is used to treat acromegaly and to reduce flushing episodes and watery diarrhea caused ...
Mycapssa
Mycapssa (octreotide) is used for the treatment of acromegaly. Includes Mycapssa side effects ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Bynfezia Pen
Bynfezia Pen (octreotide) is used to treat acromegaly and to reduce flushing episodes and watery ...
Signifor
Signifor (pasireotide) is a man-made protein that is similar to somatostatin and is used to treat ...
Somatuline Depot
Somatuline Depot is used as a long-term treatment for acromegaly. Learn about side effects ...
Octreotide
Octreotide is used for acromegaly, carcinoid tumor, diabetes, type 1, diarrhea, dumping syndrome ...
Lanreotide
Lanreotide (Somatuline Depot) is an injectable medication containing a man-made (synthetic ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.